In this episode, I explore the exciting new development of a once-daily oral weight loss medication, oral semaglutide 50mg highlighting results from the OASIS 1 trial. With this, I explain how this pill could be a game-changer for people who are hesitant about injections like Wegovy or Zepbound. I break down how semaglutide works as a GLP-1 receptor agonist, the phases of drug development, and the impressive trial results showing an average 15% body weight loss in participants without diabetes. I also talk about common side effects, the FDA approval timeline, and what this could mean for patients looking for more accessible, convenient weight loss options.
Curious about the future of weight loss treatments? Tune in to learn about a groundbreaking pill that could change everything.
============================
FOLLOW ME 👇
Facebook: https://www.facebook.com/drshellymd
Instagram: https://www.instagram.com/drshellymd/
Twitter: https://twitter.com/drshellymd
LinkedIn: https://www.linkedin.com/in/drshellymd/
Website: https://drshellymd.com/
Podcast: https://drshellymd.com/podcast/
============================